Recommended Conferences

Clinical Microbiology and Infectious Diseases

Miami, USA

Fungal Infections and Treatments

Miami, USA

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

1α, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

Author(s): Lemire JM, Adams JS, Sakai R, Jordan SC

Abstract

Activated B and T lymphocytes from normal human subjects are known to have the specific high-affinity receptor for 1,25-dihydroxyvitamin D3 (1,25-(OH)2-D3). In an attempt to determine a functional role for the sterol in such cells, we studied the effect of 1,25-(OH)2-D3 on DNA synthesis and Ig production by normal human peripheral blood mononuclear (PBM) cells activated in vitro by the polyclonal lymphocyte activators pokeweed mitogen and phytohemagglutinin, and the specific antigen dermatophyton O. A dose-dependent inhibition of [3H]thymidine incorporation was observed in cells incubated with 1,25-(OH)2-D3 in concentrations ranging from 10(-10) to 10(-7) M. Production of IgG and IgM, determined by enzyme-linked immunosorbent assay, was similarly inhibited by increasing concentrations of 1,25-(OH)2-D3. Half-maximal inhibition of DNA and Ig synthesis was found at 10(-10) to 10(-9) M 1,25-(OH)2-D3. This suppressive effect was specific for 1,25-(OH)2-D3; of the other vitamin D metabolites examined, only 10(-7) M 24R,25 dihydroxyvitamin D3 (24,25-(OH)2-D3) had a similar inhibitory effect. 1,25-(OH)2-D3 was not cytotoxic and did not affect unactivated PBMs. These data demonstrate that 1,25-(OH)2-D3 is a potent inhibitor of human PBM Ig production in vitro and suggest that this action is mediated through the hormone's antiproliferative effect on Ig-producing B cells and/or helper T cells.

Similar Articles

Vitamin D

Author(s): Dusso A, Brown A, Slatopolsky E

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study

Author(s): Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al.

Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study

Author(s): Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC

Vitamin D status in patients with chronic plaque psoriasis

Author(s): Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, et al.

Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline

Author(s): Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.

Immunocytochemical localization of the 1,25-dihydroxyvitamin-D3 receptor in target cells

Author(s): Clemens TL, Garrett KP, Zhou XY, Pike JW, Haussler MR, et al.

Vitamin D and autoimmune rheumatologic disorders

Author(s): Plajo CF, Lopez-Benitez JM, Miller LC

Influence of narrowband UVB phototherapy on vitamin D and folate status

Author(s): Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Tam TT, et al.

The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland

Author(s): Ryan C, Moran B, McKenna MJ, Murray BF, Brady J, et al.

Narrowband ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation

Author(s): Ala-houhala MJ, Karppinen TT, Vahavihu K, Kautiainen H, Dombrowski Y, et al.

Vitamin D status in psoriasis patients during different treatments with phototherapy

Author(s): Osmancevic A, Landin-Wilhelmsen K, Larko O, Krogstad AL

Serum levels of 25-hydroxy vitamin D in psoriatic patients

Author(s): Zuchi MF, Azevedo Pde O, Tanaka AA, Schmitt JV, Martins LE

Serum 25- OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects

Author(s): Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A

Vitamin D receptor polymorphism is associated with psoriasis

Author(s): Park BS, Park JS, Lee DY, Youn JI, Kim IG

Vitamin D receptor polymorphisms and diseases

Author(s): Valdivielso JM, Fernandez E